Palisade Capital Management LLC NJ bought a new stake in AptarGroup, Inc. (NYSE:ATR – Get Rating) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 2,600 shares of the industrial products company’s stock, valued at approximately $305,000.
A number of other institutional investors and hedge funds have also recently bought and sold shares of ATR. UMB Bank N A MO purchased a new stake in AptarGroup in the 4th quarter valued at approximately $28,000. Lumature Wealth Partners LLC lifted its stake in shares of AptarGroup by 64.2% during the 4th quarter. Lumature Wealth Partners LLC now owns 261 shares of the industrial products company’s stock worth $32,000 after purchasing an additional 102 shares during the period. Quadrant Capital Group LLC lifted its stake in shares of AptarGroup by 129.7% during the 1st quarter. Quadrant Capital Group LLC now owns 395 shares of the industrial products company’s stock worth $47,000 after purchasing an additional 223 shares during the period. MV Capital Management Inc. purchased a new position in shares of AptarGroup during the 4th quarter worth $49,000. Finally, Alpha Paradigm Partners LLC purchased a new position in shares of AptarGroup during the 4th quarter worth $57,000. Hedge funds and other institutional investors own 87.70% of the company’s stock.
AptarGroup Trading Down 0.7 %
ATR stock opened at $105.65 on Friday. The company has a market cap of $6.90 billion, a price-to-earnings ratio of 30.80, a PEG ratio of 3.93 and a beta of 0.62. The company has a quick ratio of 1.32, a current ratio of 1.90 and a debt-to-equity ratio of 0.65. The business has a fifty day simple moving average of $103.43 and a 200-day simple moving average of $110.83. AptarGroup, Inc. has a 52 week low of $94.03 and a 52 week high of $136.23.
AptarGroup Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 17th. Investors of record on Wednesday, July 27th will be issued a $0.38 dividend. The ex-dividend date is Tuesday, July 26th. This represents a $1.52 annualized dividend and a yield of 1.44%. AptarGroup’s dividend payout ratio is currently 44.31%.
Analysts Set New Price Targets
A number of research analysts have weighed in on the company. Morgan Stanley reduced their price target on AptarGroup from $126.00 to $120.00 and set an “equal weight” rating on the stock in a research note on Tuesday. Wells Fargo & Company reduced their price target on AptarGroup from $150.00 to $125.00 and set an “overweight” rating on the stock in a research note on Monday, July 18th. TheStreet lowered AptarGroup from a “b-” rating to a “c+” rating in a research note on Thursday, June 16th. Deutsche Bank Aktiengesellschaft dropped their price objective on AptarGroup from $145.00 to $125.00 in a report on Tuesday, July 19th. Finally, Robert W. Baird dropped their price objective on AptarGroup from $125.00 to $110.00 and set a “neutral” rating for the company in a report on Monday, August 1st. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, AptarGroup presently has a consensus rating of “Hold” and an average price target of $120.00.
Insider Activity at AptarGroup
In related news, insider Gael Touya sold 59,072 shares of the stock in a transaction on Monday, June 6th. The stock was sold at an average price of $108.98, for a total value of $6,437,666.56. Following the completion of the sale, the insider now directly owns 38,876 shares in the company, valued at approximately $4,236,706.48. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.20% of the stock is owned by insiders.
AptarGroup, Inc provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage.
- Get a free copy of the StockNews.com research report on AptarGroup (ATR)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for AptarGroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AptarGroup and related companies with MarketBeat.com's FREE daily email newsletter.